Saturday, November 5, 2016

Wheel of Fortune (1952) -- Kay Starr (1922 to 2016, RIP)

St. Petersburg, Florida (1952)






The wheel of fortune
Goes spinning around
Will the arrow point my way
Will this be my day
Oh, wheel of fortune
Please don't pass me by
Let me know the magic of
A kiss and a sign
While the wheel is spinning, spinning, spinning
I'll not dream of winning fortune or fame
While the wheel is turning, turning, turning
I'll be yearning, yearning
For love's precious flame
Oh, wheel of fortune
I'm hoping somehow
If you'll ever smile on me
Please let it be now
While the wheel is spinning, spinning, spinning
I'll not dream of winning fortune or fame
While the wheel is turning, turning, turning
I'll be yearning, yearning
For love's precious flame
Oh, wheel of fortune
I'm hoping somehow
If you ever smile on me
Please let it be now




Friday, November 4, 2016

Try dressing and speaking like a grown-up

Image result for college students 1952
Boston University students cutting loose in the 1950s.





"Ken Woodward recalls that some time in the early seventies he noted a change in the dress and speech of grown-ups. The difference was simple: Adults had begun to act like adolescents.
My wife was working the local precincts [during the 1972 campaign], where I was surprised to find that most of the middle-aged women working with her were wearing blue jeans. Hard to believe now, but blue jeans had become the uniform of campus rebels and symbolic of youth in general only a few years earlier.
The jeans didn’t fit very well, Woodward comments, but that didn’t matter. These women supported Eugene McCarthy, and “they were determined to dress as young as the college kids who in 1968 had [gone] ‘clean for Gene.’”
 
They and other older people adopted a youth idiom, too.
Until the seventies, I never heard adults routinely use expressions like “wow” and “cool” as one-syllable substitutes for real conversation.
I imagine that nobody reading this needs to be convinced of the depleted lexicon of young and middle-aged Americans. Woodward’s explanation is that the seventies and beyond marked a shift in the meaning of youth. People wanted to stay young far beyond the traditional age, and “the young were taking longer to grow up.” More of them were going to college (which, though he doesn't say this, steadily has become an enclave in which adolescence may be perpetuated), and they waited longer to get married. It was great to be young in 1968, and they wanted it to last forever.
 
The problem certainly has become worse, with adolescent lingo now the norm for thirty- and forty-year-olds. Cool and awesome are the worst ones, catch-all terms for anything that is pleasing or blandly unusual. (There is no longer any awe in awesome.)"
 









Thursday, November 3, 2016

Socrates endorses Trump?

Image result for Socrates

Ancient and Modern Rhetoric (blog)
"In a long and fascinating segment of his written ‘memoirs’ about the philosopher Socrates (the Memorabilia), Xenophon recalls some conversations which Socrates supposedly had with various interlocutors on the subject of military and political leadership.   In one of them, a certain Nicomachides complains that the Athenians have elected a businessman called Antisthenes to a generalship rather than himself (3.4.1):
“Isn’t it like the Athenians? … they haven’t chosen me after all the hard work I have done, since I was called up, in the command of company or regiment, though I have been so often wounded in action” (and here he uncovered and showed his scars); “yet they have chosen Antisthenes, who has never served as a hoplite nor distinguished himself in the cavalry and understands nothing but money-making.”
Socrates points out that Antisthenes has often also been a choregos  (financier and impresario of dramatic and dithyrambic choruses in festival contests).  Antisthenes’ choruses have always won the contest the because he is philonikos (eager for victory). Surely this is a good trait for a general?   
Nicomachides doubts the cogency of any analogy between the handling of a chorus and of an army.  Socrates clarifies as follows  (3.4.4):
“But, you see,” said Socrates, “though Antisthenes knows nothing about music or chorus training, he showed himself capable of finding the best experts in these.”  
“In the army too, then,” said Nicomachides, “he will find other to command for him, and others to do the fighting. Do you mean to say, Socrates, that the man who succeeds with a chorus will also succeed with an army?”
“I mean that, whatever a man is a leader of (prostateuei), if he knows what he wants and can get it he will be a good leader (agathos prostates), whether he is leader of a chorus, an estate, a city or an army.”



 

Wednesday, November 2, 2016

Anderson Cooper and the Schizophrenia Simulator


Image result for anderson cooper schizophrenia
"It's a very unpleasant experience...Really depressing...It's creepy; I want it to stop."




Psychiatric Times
"The most common type of auditory hallucinations in psychiatric illness consists of voices. Voices may be male or female, and with intonations and accents that typically differ from those of the patient. Persons who have auditory hallucinations usually hear more than one voice, and these are sometimes recognized as belonging to someone who is familiar (such as a neighbor, family member, or TV personality) or to an imaginary character (God, the devil, an angel). Verbal hallucinations may comprise full sentences, but single words are more often reported.
Voices that comment on or discuss the individual’s behavior and that refer to the patient in the third person were thought by Schneider13 to be first-rank symptoms and of diagnostic significance for schizophrenia. Studies show that approximately half of patients with schizophrenia experience these symptoms.14
A significant proportion of patients also experience nonverbal hallucinations, such as music, tapping, or animal sounds, although these experiences are frequently overlooked in auditory hallucinations research. Another type of hallucination includes the experience of functional hallucinations, in which the person experiences auditory hallucinations simultaneously through another real noise (eg, a person may perceive auditory hallucinations only when he hears a car engine).
The content of voices varies between individuals. Often the voices have a negative and malicious content. They might speak to the patient in a derogatory or insulting manner or give commands to perform an unacceptable behavior. The experience of negative voices causes considerable distress.12 However, a significant proportion of voices are pleasant and positive, and some individuals report feelings of loss when the treatment causes the voices to disappear.15 "

Tuesday, November 1, 2016

O, Canada. You're letting the psychopaths out on parole.

Image result for parole board
In Canada, psychopaths convicted of sexual offenses are 2.5 times more likely to be granted parole than non-psychopaths, even though they have worse criminal records. The authors suggest that it is because psychopaths are more adept at "charming" parole boards. Whom do you like better: Someone who is nervous, twitchy, and socially awkward, or the guy who makes you laugh? The psychopaths made it 388 days without being convicted for re-offending, versus 729 days for non-psychopaths.


Crime profiles and conditional release performance of psychopathic and non-psychopathic sexual offenders (Porter, ten Brinke, & Wilson, 2009)

Abstract

Purpose. This study investigated the influence of psychopathy and sex offender subtype on criminal history, probability of being granted conditional release, and performance while on conditional release in a diverse group of violent offenders. We predicted that psychopathic sexual offenders would be associated with relatively prolific violent and sexual offending, a high probability of successful conditional release applications despite their past behaviour (resulting from ‘putting on a good show’ in a parole hearing), and poor performance in the community.
Methods. Information was gathered via a correctional file review of 310 Canadian male federal offenders. Offenders were categorized into groups based on their sexual offence history (non-sex offender, rapist, child molester, or mixed rapist/molester) and Psychopathy Checklist – Revised (PCL-R; Hare, 2003) ratings. Their offences (sexual, violent, or non-violent) and their complete conditional release histories were coded.
Results. Psychopathy was associated with more violent and non-violent, but not sexual, offences. A significant interaction between psychopathy and offender subtype revealed that psychopathy was associated with a greater number of sex offences within child molesters. High-psychopathy offenders (both sexual and non-sexual offenders) were about 2.5 times more likely to be granted conditional release than non-psychopathic offenders.
Conclusions. Psychopathy is associated with more prolific sexual offending among child molesters and – despite their extensive criminal histories and high recidivism rate – a great proficiency in persuading parole boards to release them into the community. Specialized education and training in dealing with psychopathic offenders is urgently needed.


Monday, October 31, 2016

"Psychopharmacology is in crisis"

Image result for new drugs of psychiatry
When are all the new drugs for psychiatric disorders coming along? Probably not in your lifetime.


Schizophrenia Bulletin, Fibiger (2012)
"Psychopharmacology is in crisis. The data are in, and it is clear that a massive experiment has failed: despite decades of research and billions of dollars invested, not a single mechanistically novel drug has reached the psychiatric market in more than 30 years. Indeed, despite enormous effort, the field has not been able to escape the “me too/me (questionably) better” straightjacket. In recent years, the appreciation of this reality has had profound consequences for innovation in psychopharmacology because nearly every major pharmaceutical company has either reduced greatly or abandoned research and development of mechanistically novel psychiatric drugs. This decision is understandable because pharmaceutical and biotechnology executives see less risky opportunities in other therapeutic areas, cancer and immunology being the current pipeline favorites. Indeed, in retrospect, one can wonder why it took so long for industry to abandon psychiatry therapeutics. So how did we get here and more importantly, what do we need to do to find a way forward?            
The discovery of all three major classes of psychiatric drugs, antidepressants, antipsychotics, and anxiolytics, came about on the basis of serendipitous clinical observation. [Also known as dumb luck.] At the time of their discoveries, the mechanisms by which these molecules produce their effects were unknown, and it was only later that antipsychotics were shown to be D2 receptor antagonists, antidepressants monoamine reuptake inhibitors, and anxiolytics GABA receptor modulators. It is interesting and perhaps instructive to consider whether any of these classes of drugs could have been discovered by current drug discovery strategies. For example, what genetic or preclinical data exist that point to the D2 dopamine receptor as a likely target for antipsychotic activity? Presently there are no genetic data that suggest that this receptor is expressed or functions abnormally in psychotic disorders. And without the benefit of the prior clinical validation, it is difficult to see how preclinical data alone would point to the D2 receptor as an interesting potential target for the treatment of psychotic disorders. The same can be said for monoamine transporters with respect to depression where, like psychosis, there are no animal models based on disease pathophysiology and no compelling preclinical data pointing to these as potential targets for antidepressant drugs. This raises a troubling question: if in retrospect the three major classes of currently prescribed psychiatric drugs would likely never have been discovered using current drug discovery strategies, why should we believe that such strategies are likely to bear fruit now or in the future?               
In order to recapture industry’s investment in psychiatric drug development, major changes in psychiatry will need to take place. These changes are necessary along the entire value chain, including both preclinical and clinical domains. What the field lacks is sufficient basic knowledge about normal brain function and how its disturbance underlies the pathophysiology of psychiatric disease. Because of this, as the record now clearly shows, it remains too early to attempt rational drug design for psychiatric diseases as currently conceived. The most obvious solution here is expanded investment in neuroscience. By necessity, this will be driven primarily by the efforts of clinical and basic scientists in academic settings because industry no longer has the appetite or the resources to engage in such activities. It is worth emphasizing that industry is in the business of making drugs, knowledge sometimes being a fortuitous byproduct. Academia is in the business of generating knowledge, and knowledge is what is needed at present. If we are successful in making the necessary changes, given the enormous level of unmet need left by existing psychiatric drugs, there is no doubt that industry will return and reinvest.                 
A major barrier to progress is the current state of nosology in psychiatry. A new taxonomy is a prerequisite for meaningful progress. Today, few would argue that syndromes such as schizophrenia and depression are single, homogeneous diseases. And yet when it comes to clinical research, including clinical trials, both are still almost always treated as such. For example, studies continue to be published on the genetics of both of these syndromes despite the fact that there never will be a robust genetics of either condition as the nature and severity of specific symptoms are too heterogeneous across individuals to have any consistent genetic correlates. Similarly, while DSM conceptualizations of psychiatric disease may have utility in current clinical practice, when it comes to research, they too are a barrier to progress. A different approach would be to break these syndromes down into their component subsyndromes or symptoms and investigate the neurobiological substrates of these more precisely defined components. As an example, although there will never be a coherent biology of schizophrenia (any more than there ever could have been be a meaningful biology of cancer as it was understood 30 years ago), the chances seem better that there will be a biology of subsyndromes such as negative symptoms, delusions, or hallucinations (just as it is now understood that there are distinct biologies underlying different cancers). Advances in knowledge about the biological mechanisms underlying different cancers are were a prerequisite for the huge current investment in developing novel cancer therapeutics. Psychiatry should learn from this example.                 
Given that there cannot be a coherent biology for syndromes as heterogeneous as schizophrenia, it is not surprising that the field has failed to validate distinct molecular targets for the purpose of developing mechanistically novel therapeutics."




Sunday, October 30, 2016

You tell me this is God? -- Stephen Crane

Image result for ancient text and candle


You tell me this is God?
I tell you this is a printed list,
A burning candle and an ass.